CV Sciences, Inc., a consumer health firm based in San Diego, has unveiled PlusHLTH.com, a new direct-to-consumer website aimed at promoting the company’s +PlusHLTH™ product line. This strategic move represents a significant step in the company’s aim to diversify beyond its established cannabinoid products and into broader health solutions that address aging and wellness.
PlusHLTH.com is designed to serve as a comprehensive platform where consumers can explore a variety of science-backed nutritional products and educational content. The site aims to assist individuals in understanding their health needs and finding effective solutions as they navigate aging. In contrast, CV Sciences' existing platform, PlusCBDOil.com, continues to concentrate on its well-known CBD offerings.
The website curates various non-cannabinoid nutritional supplements, including targeted dietary supplements in both capsule and gummy forms, as well as Empowr, a plant-based protein combined with creatine. The launch is expected to facilitate greater consumer engagement by providing easily accessible information about product benefits and health insights.
Joseph Dowling, the Chief Executive Officer of CV Sciences, described the launch as a pivotal evolution for the company. He emphasized that the brand is committed to quality and innovation, building on the established trust gained from its previous health solutions, notably the PlusCBD brand. Dowling noted that PlusHLTH.com allows for a distinctive digital space to introduce new products while evolving alongside consumers’ health journeys.
CV Sciences plans to expand the +PlusHLTH™ product range by introducing new formulations and delivery methods, responding to shifting consumer demands within the health and wellness space. The new platform will be essential in establishing a brand identity for +PlusHLTH™ and driving consumer education and product accessibility.
PlusHLTH.com is a new digital platform launched by CV Sciences, Inc. (OTCQB:CVSI) dedicated to the company's +PlusHLTH™ product line. It focuses on providing consumers with science-backed solutions and educational content related to healthy aging and wellness. The site features non-cannabinoid nutritional products, such as dietary supplements and a plant-based protein.
The launch of PlusHLTH.com represents a strategic move by CV Sciences to expand beyond its cannabinoid products and establish +PlusHLTH™ as a significant brand in the health sector. The initiative aims to create a dedicated platform for consumers to engage with a wider range of health solutions and educational resources.
The +PlusHLTH™ line includes non-cannabinoid nutritional products such as targeted dietary supplements in capsule and gummy forms, as well as Empowr, a plant-based protein with creatine. The company intends to continue expanding this product line with further innovations.
The term 'Health Intelligence' refers to CV Sciences' approach that combines educational content with products to assist consumers in understanding their health needs. This concept underpins the operations of PlusHLTH.com, aiming to empower users in making informed health choices.
PlusHLTH.com focuses on the company's expanding range of +PlusHLTH™ non-cannabinoid products and wellness solutions, whereas PlusCBDOil.com is dedicated to CV Sciences' well-established hemp-derived CBD portfolio.
The +PlusCBD™ brand under CV Sciences is noted for having achieved Generally Recognized as Safe (GRAS) status and is backed by clinical research and scientific studies. However, the new +PlusHLTH™ products do not have the same established track record and consumer validation.
As stated in their communications, CV Sciences acknowledges the risks and uncertainties related to its growth strategy and product expansions. Investors should note that these factors may influence actual results, which could differ from their projections.
Further information about CV Sciences, Inc. (OTCQB:CVSI) and its product lines can be found on their official website at www.cvsciences.com.